The rise of specialized therapeutic areas, such as oncology and immunology, has necessitated a shift toward niche Functional Service Providers who possess deep domain expertise in these complex fields within the GCC in late 2025. These specialized FSPs provide clinicians with the specific knowledge required to manage trials involving advanced biologics, cell therapies, and targeted molecular...